Pharmacophore-based virtual screening.
暂无分享,去创建一个
[1] Horvath Dragos,et al. Predicting the predictability: a unified approach to the applicability domain problem of QSAR models. , 2009, Journal of chemical information and modeling.
[2] I. Bahar,et al. Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model. , 2009, Journal of medicinal chemistry.
[3] Osman F. Güner,et al. Pharmacophore perception, development, and use in drug design , 2000 .
[4] M. Taha,et al. Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. , 2008, Journal of medicinal chemistry.
[5] Salvatore Cannistraro,et al. Docking study and free energy simulation of the complex between p53 DNA‐binding domain and azurin , 2007, Journal of molecular recognition : JMR.
[6] Valerie J. Gillet,et al. SPROUT: A program for structure generation , 1993, J. Comput. Aided Mol. Des..
[7] Thierry Langer,et al. Efficient overlay of small organic molecules using 3D pharmacophores , 2007, J. Comput. Aided Mol. Des..
[8] Thierry Langer,et al. Comparative Analysis of Protein-Bound Ligand Conformations with Respect to Catalyst's Conformational Space Subsampling Algorithms , 2005, J. Chem. Inf. Model..
[9] Maykel Pérez González,et al. Variable selection methods in QSAR: an overview. , 2008, Current topics in medicinal chemistry.
[10] Dragos Horvath,et al. Fuzzy Tricentric Pharmacophore Fingerprints. 2. Application of Topological Fuzzy Pharmacophore Triplets in Quantitative Structure-Activity Relationships , 2008, J. Chem. Inf. Model..
[11] Gert Thijs,et al. Pharao: pharmacophore alignment and optimization. , 2008, Journal of molecular graphics & modelling.
[12] Philip M. Dean,et al. QUASI: A Novel Method for Simultaneous Superposition of Multiple Flexible Ligands and Virtual Screening Using Partial Similarity , 2007, J. Chem. Inf. Model..
[13] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[14] A. Good,et al. 3-D pharmacophores in drug discovery. , 2001, Current pharmaceutical design.
[15] Olivier Sperandio,et al. Combining Ligand- and Structure-Based Methods in Drug Design Projects , 2008 .
[16] John H. Van Drie,et al. Computer-aided drug design: the next 20 years , 2007, J. Comput. Aided Mol. Des..
[17] Jiabo Li,et al. CAESAR: A New Conformer Generation Algorithm Based on Recursive Buildup and Local Rotational Symmetry Consideration , 2007, J. Chem. Inf. Model..
[18] Dimitris K. Agrafiotis,et al. A self‐organizing algorithm for molecular alignment and pharmacophore development , 2008, J. Comput. Chem..
[19] J. Ponder,et al. Force fields for protein simulations. , 2003, Advances in protein chemistry.
[20] D. Ritchie,et al. Protein docking using spherical polar Fourier correlations , 2000, Proteins.
[21] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[22] D Horvath,et al. From hit to lead. Combining two complementary methods for focused library design. Application to mu opiate ligands. , 2001, Journal of medicinal chemistry.
[23] Federico Corelli,et al. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo. , 2009, Journal of medicinal chemistry.
[24] Maxim Totrov,et al. Atomic Property Fields: Generalized 3D Pharmacophoric Potential for Automated Ligand Superposition, Pharmacophore Elucidation and 3D QSAR , 2007, Chemical biology & drug design.
[25] Thomas Sander,et al. Flexophore, a New Versatile 3D Pharmacophore Descriptor That Considers Molecular Flexibility , 2008, J. Chem. Inf. Model..
[26] Eric J. Martin,et al. Surrogate AutoShim: Predocking into a Universal Ensemble Kinase Receptor for Three Dimensional Activity Prediction, Very Quickly, without a Crystal Structure , 2008, J. Chem. Inf. Model..
[27] Ingo Muegge. Synergies of virtual screening approaches. , 2008, Mini reviews in medicinal chemistry.
[28] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[29] Nicolas Foloppe,et al. Conformational Sampling of Druglike Molecules with MOE and Catalyst: Implications for Pharmacophore Modeling and Virtual Screening , 2008, J. Chem. Inf. Model..
[30] Suzanne C Brewerton,et al. The use of protein-ligand interaction fingerprints in docking. , 2008, Current opinion in drug discovery & development.
[31] Xicheng Wang,et al. Cyndi: a multi-objective evolution algorithm based method for bioactive molecular conformational generation , 2009, BMC Bioinformatics.
[32] C. Griesinger,et al. Specific methyl group protonation for the measurement of pharmacophore-specific interligand NOE interactions. , 2008, Chemistry.
[33] B Montgomery Pettitt,et al. The dewetting transition and the hydrophobic effect. , 2007, Journal of the American Chemical Society.
[34] Valerie J. Gillet,et al. Incorporating partial matches within multiobjective pharmacophore identification , 2006, J. Comput. Aided Mol. Des..
[35] yderis p,et al. ISI Web of Knowledge. , 2013 .
[36] H. Prinz. How to identify a pharmacophore. , 2008, Chemistry & biology.
[37] Paul Watson,et al. Naïve Bayes Classification Using 2D Pharmacophore Feature Triplet Vectors , 2008, J. Chem. Inf. Model..
[38] Alexander D. MacKerell,et al. Comparison of protein force fields for molecular dynamics simulations. , 2008, Methods in molecular biology.
[39] J. A. Grant,et al. A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape , 1996, J. Comput. Chem..
[40] Anton J. Hopfinger,et al. Rational Design and 3D-Pharmacophore Mapping of 5′-Thiourea-Substituted α-Thymidine Analogues as Mycobacterial TMPK Inhibitors , 2009, J. Chem. Inf. Model..
[41] Gisbert Schneider,et al. Structure‐Based Pharmacophore Screening for Natural‐Product‐Derived PPARγ Agonists , 2009, Chembiochem : a European journal of chemical biology.
[42] Gregory A Landrum,et al. Conformation mining: an algorithm for finding biologically relevant conformations. , 2005, Journal of medicinal chemistry.
[43] Anders Karlén,et al. Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering. , 2008, Journal of molecular graphics & modelling.
[44] Michiko Amano,et al. Novel Method for the Evaluation of 3D Conformation Generators , 2009, J. Chem. Inf. Model..
[45] Nanda Ghoshal,et al. An efficient tool for identifying inhibitors based on 3D-QSAR and docking using feature-shape pharmacophore of biologically active conformation--a case study with CDK2/cyclinA. , 2008, European journal of medicinal chemistry.
[46] Kyoung Tai No,et al. Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation. , 2009, Bioorganic & medicinal chemistry.
[47] Ruth Nussinov,et al. Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.
[48] K. Zhao,et al. A three-dimensional pharmacophore model for RXRα agonists , 2009 .
[49] Thierry Langer,et al. LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..
[50] Chris G. Kruse,et al. Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints. , 2008, Journal of medicinal chemistry.
[51] Yu Xue,et al. MBA: a literature mining system for extracting biomedical abbreviations , 2009, BMC Bioinformatics.
[52] Olivier Sperandio,et al. MED-3DMC: a new tool to generate 3D conformation ensembles of small molecules with a Monte Carlo sampling of the conformational space. , 2009, European journal of medicinal chemistry.
[53] David W. Ritchie,et al. Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening , 2009, J. Chem. Inf. Model..
[54] D. Douguet. Ligand-Based Approaches in Virtual Screening , 2008 .
[55] Gabriele Cruciani,et al. A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application , 2007, J. Chem. Inf. Model..
[56] Thierry Langer,et al. Comparative Performance Assessment of the Conformational Model Generators Omega and Catalyst: A Large-Scale Survey on the Retrieval of Protein-Bound Ligand Conformations , 2006, J. Chem. Inf. Model..
[57] Y. Kurogi,et al. Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. , 2001, Current medicinal chemistry.
[58] Wolfgang Guba,et al. Recent developments in de novo design and scaffold hopping. , 2008, Current opinion in drug discovery & development.
[59] Thomas Sander,et al. Comparison of Ligand- and Structure-Based Virtual Screening on the DUD Data Set , 2009, J. Chem. Inf. Model..
[60] Areej M. Abu Hammad,et al. Pharmacophore Modeling, Quantitative Structure-Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza Neuraminidase Inhibitors , 2009, J. Chem. Inf. Model..
[61] Hans Matter,et al. Comparing 3D Pharmacophore Triplets and 2D Fingerprints for Selecting Diverse Compound Subsets , 1999, J. Chem. Inf. Comput. Sci..
[62] Weifan Zheng,et al. Novel Approach to Structure-Based Pharmacophore Search Using Computational Geometry and Shape Matching Techniques , 2008, J. Chem. Inf. Model..
[63] David Baker,et al. Protein-protein docking with backbone flexibility. , 2007, Journal of molecular biology.
[64] Campbell McInnes,et al. Virtual screening strategies in drug discovery. , 2007, Current opinion in chemical biology.
[65] Heather A Carlson,et al. Protein flexibility and species specificity in structure-based drug discovery: dihydrofolate reductase as a test system. , 2007, Journal of the American Chemical Society.
[66] D. Horvath,et al. G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation. , 2005, Journal of medicinal chemistry.
[67] Dragos Horvath,et al. Development and Validation of a Pharmacophore‐Based QSAR Model for the Prediction of CNS Activity , 2009, ChemMedChem.
[68] S Vadivelan,et al. Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models. , 2009, European journal of medicinal chemistry.
[69] Dragos Horvath,et al. QSAR Strategy and Experimental Validation for the Development of a GPCR Focused Library , 2005 .
[70] W L Jorgensen,et al. Rusting of the lock and key model for protein-ligand binding. , 1991, Science.
[71] Hans-Joachim Böhm,et al. The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..
[72] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[73] Hongma Sun,et al. Pharmacophore-based virtual screening. , 2008, Current medicinal chemistry.
[74] Atul J. Butte,et al. The "etiome": identification and clustering of human disease etiological factors , 2009, BMC Bioinformatics.
[75] David E. Clark,et al. PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology , 1997, J. Comput. Aided Mol. Des..
[76] Richard D. Taylor,et al. Improved protein–ligand docking using GOLD , 2003, Proteins.
[77] David A. Evans,et al. Predicting the Accuracy of Ligand Overlay Methods with Random Forest Models , 2008, J. Chem. Inf. Model..
[78] Gisbert Schneider,et al. PhAST: pharmacophore alignment search tool , 2009, J. Comput. Chem..
[79] P. Charifson,et al. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.
[80] Thierry Langer,et al. Fast and Efficient in Silico 3D Screening: Toward Maximum Computational Efficiency of Pharmacophore-Based and Shape-Based Approaches , 2007, J. Chem. Inf. Model..
[81] Todd J. A. Ewing,et al. Critical evaluation of search algorithms for automated molecular docking and database screening , 1997 .
[82] Ying Leng,et al. Structure-based virtual screening for identification of novel 11 beta-HSD1 inhibitors , 2009 .
[83] Igor V. Tetko,et al. Critical Assessment of QSAR Models of Environmental Toxicity against Tetrahymena pyriformis: Focusing on Applicability Domain and Overfitting by Variable Selection , 2008, J. Chem. Inf. Model..
[84] Jaime Rubio-Martinez,et al. Mimicking direct protein–protein and solvent-mediated interactions in the CDP-methylerythritol kinase homodimer: a pharmacophore-directed virtual screening approach , 2009, Journal of molecular modeling.
[85] Michael R Shirts,et al. Parallelized-over-parts computation of absolute binding free energy with docking and molecular dynamics. , 2006, The Journal of chemical physics.
[86] Benjamin Parent,et al. Fuzzy Tricentric Pharmacophore Fingerprints, 1. Topological Fuzzy Pharmacophore Triplets and Adapted Molecular Similarity Scoring Schemes , 2006, J. Chem. Inf. Model..
[87] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[88] Ying Leng,et al. Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors. , 2009, European journal of medicinal chemistry.
[89] Luhua Lai,et al. Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. , 2008, Journal of medicinal chemistry.
[90] Cristina Tintori,et al. Targets Looking for Drugs: A Multistep Computational Protocol for the Development of Structure-Based Pharmacophores and Their Applications for Hit Discovery , 2008, J. Chem. Inf. Model..
[91] Darren Vs Green,et al. Virtual screening of chemical libraries for drug discovery , 2008, Expert opinion on drug discovery.
[92] Yu-Quan Wei,et al. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2. , 2008, Journal of molecular graphics & modelling.
[93] Jonathan W. Essex,et al. A review of protein-small molecule docking methods , 2002, J. Comput. Aided Mol. Des..
[94] Thomas Lengauer,et al. FlexE: efficient molecular docking considering protein structure variations. , 2001, Journal of molecular biology.
[95] Jürgen Bajorath,et al. Development of a Fingerprint Reduction Approach for Bayesian Similarity Searching Based on Kullback-Leibler Divergence Analysis , 2009, J. Chem. Inf. Model..
[96] George Karypis,et al. Common Pharmacophore Identification Using Frequent Clique Detection Algorithm , 2009, J. Chem. Inf. Model..
[97] Gilles Marcou,et al. Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints , 2007, J. Chem. Inf. Model..
[98] Petra Schneider,et al. Scaffold Hopping by “Fuzzy” Pharmacophores and its Application to RNA Targets , 2007, Chembiochem : a European journal of chemical biology.
[99] Benjamin Parent,et al. Optimized Evolutionary Strategies in Conformational Sampling , 2006, Soft Comput..
[100] Timothy Clark,et al. An analytical, variable resolution, complete description of static molecules and their intermolecular binding properties. , 2005, Journal of chemical information and modeling.
[101] Dimitris K. Agrafiotis,et al. Recursive Distance Partitioning Algorithm for Common Pharmacophore Identification , 2007, J. Chem. Inf. Model..
[102] Bjørn K. Alsberg,et al. An alignment‐free methodology for modelling field‐based 3D‐structure activity relationships using inductive logic programming , 2007 .
[103] Dragos Horvath,et al. Strengths and Limitations of Pharmacophore‐Based Virtual Screening , 2005 .
[104] Anna Linusson,et al. SHOP: scaffold HOPping by GRID-based similarity searches. , 2007, Journal of medicinal chemistry.
[105] Robert D. Clark,et al. Parameterization and Conformational Sampling Effects in Pharmacophore Multiplet Searching , 2008, J. Chem. Inf. Model..
[106] Stephen Muggleton,et al. Scaffold Hopping in Drug Discovery Using Inductive Logic Programming , 2008, J. Chem. Inf. Model..
[107] David T Manallack,et al. The use of local surface properties for molecular superimposition , 2008, Journal of molecular modeling.
[108] Matthias Rarey,et al. Beyond the Virtual Screening Paradigm: Structure-Based Searching for New Lead Compounds , 2009, J. Chem. Inf. Model..
[109] Olivier Sperandio,et al. MED-SuMoLig: A New Ligand-Based Screening Tool for Efficient Scaffold Hopping , 2007, J. Chem. Inf. Model..
[110] Masilamani Elizabeth Sobhia,et al. Fingerprint Directed Scaffold Hopping for Identification of CCR2 Antagonists , 2008, J. Chem. Inf. Model..
[111] Hyunah Choo,et al. Identification of novel serotonin 2C receptor ligands by sequential virtual screening. , 2009, Bioorganic & medicinal chemistry.
[112] J. A. Grant,et al. Gaussian docking functions. , 2003, Biopolymers.
[113] Simone Sciabola,et al. Pharmacophoric Fingerprint Method (TOPP) for 3D-QSAR Modeling: Application to CYP2D6 Metabolic Stability , 2007, J. Chem. Inf. Model..
[114] Sune Askjaer,et al. Combining Pharmacophore Fingerprints and PLS-Discriminant Analysis for Virtual Screening and SAR Elucidation , 2008, J. Chem. Inf. Model..
[115] Robert D. Clark,et al. A marriage made in torsional space: using GALAHAD models to drive pharmacophore multiplet searches , 2007, J. Comput. Aided Mol. Des..
[116] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to In Vitro Activity Spaces-A Benchmark for Neighborhood Behavior Assessment of Different in Silico Similarity Metrics , 2003, J. Chem. Inf. Comput. Sci..
[117] Peter Willett,et al. GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D , 2006, J. Comput. Aided Mol. Des..
[118] Johan Wouters,et al. Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors. , 2009, Bioorganic & medicinal chemistry.
[119] Rajarshi Guha,et al. Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..
[120] Santosh Putta,et al. Feature-map vectors: a new class of informative descriptors for computational drug discovery , 2007, J. Comput. Aided Mol. Des..
[121] Lester A. Mitscher,et al. Glossary of terms used in medicinal chemistry , 1998 .
[122] Osman Güner,et al. Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. , 2004, Current medicinal chemistry.
[123] Jia Jia,et al. Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries. , 2009, Combinatorial chemistry & high throughput screening.
[124] Paul Langan,et al. X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design. , 2009, Journal of structural biology.
[125] Ji-Xia Ren,et al. Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2. , 2009, Journal of molecular graphics & modelling.
[126] Gilles Marcou,et al. Hot-Spots-Guided Receptor-Based Pharmacophores (HS-Pharm): A Knowledge-Based Approach to Identify Ligand-Anchoring Atoms in Protein Cavities and Prioritize Structure-Based Pharmacophores , 2008, J. Chem. Inf. Model..
[127] Heather A Carlson,et al. Exploring experimental sources of multiple protein conformations in structure-based drug design. , 2007, Journal of the American Chemical Society.
[128] Herbert Köppen. Virtual screening - what does it give us? , 2009, Current opinion in drug discovery & development.
[129] G. T. Gunnarsson,et al. On designing non-saccharide, allosteric activators of antithrombin. , 2009, European journal of medicinal chemistry.